MNG117
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG438 | — | — | 0.870 |
| 2 | MNG356 | — | — | 0.833 |
| 3 | TCGA-78-7540-01A-11R-2066-07 | — | cohortA1 | 0.832 |
| 4 | MNG795 | — | — | 0.812 |
| 5 | MNG10 | — | — | 0.805 |
| 6 | SRR1516071 | — | — | 0.797 |
| 7 | TCGA-55-7284-01B-11R-2241-07 | — | cohortA1 | 0.789 |
| 8 | TCGA-78-7162-01A-21R-2066-07 | — | cohortA2 | 0.787 |
| 9 | 80ff3d8c-da3f-4a1f-822c-c6132e2b0574 | — | — | 0.779 |
| 10 | ERR2208890 | — | — | 0.766 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 32 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| APICAL_SURFACE | 0.429 | Temsirolimus | — uncovered |
| TGF_BETA_SIGNALING | 0.380 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.266 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.217 | Inavolisib | — uncovered |
| COAGULATION | 0.213 | Binimetinib | — uncovered |
| P53_PATHWAY | 0.212 | Idelalisib | — uncovered |
| HEME_METABOLISM | 0.211 | Temsirolimus | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.193 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.180 | Remibrutinib | — uncovered |
| COMPLEMENT | 0.174 | Inavolisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.172 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.151 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.140 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.138 | Remibrutinib | — uncovered |
| BILE_ACID_METABOLISM | 0.130 | Inavolisib | — uncovered |
| APOPTOSIS | 0.117 | Idelalisib | — uncovered |
| HYPOXIA | 0.114 | Idelalisib | — uncovered |
| PEROXISOME | 0.101 | Idelalisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.093 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.090 | Inavolisib | — uncovered |